Screening for the Early Detection of Ovarian Cancer
Screening for the Early Detection of Ovarian Cancer
复制标题
早期发现卵巢癌的筛查
DOI:
10.2217/whe.09.27
复制
发表时间:
2009
期刊:
影响因子:
--
通讯作者:
D. Robertson
中科院分区:
文献类型:
--
作者:
D. Robertson
Evaluation of: Menon U, Gentry-Maharaj A, Hallett R et al.: Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 10, 327–340 (2009). A randomized, controlled trial was undertaken to assess the use of serum CA125 and ovarian ultrasound as diagnostic markers in the early detection of ovarian cancer. The trial consisted of 202,638 postmenopausal women who were assessed annually between 2001 and 2005. A nonscreen group and two screening groups were investigated. The screening groups included serum CA125, which was based on a rate-of-change algorithm, plus transvaginal ultrasound (in at-risk women); and an ovarian ultrasound group only, prior to clinical review and surgery. The sensitivity, specificity and positive predictive values for all primary ovarian and tubal cancers for the combined test group was 89.4, 99.8 and 43.3%, respectively, and for the ultrasound group 84.9, 98.2 and 5.3%, respectively, with a significant difference in specificity between groups. The combined test provides the requisite specificity for a screening test for ovarian cancer in postmenopausal women.
DOI:
10.1783/147118909788707887
发表时间:
2009-04
影响因子:
--
作者:
U. Menon;A. Gentry-Maharaj;Rachel Hallett;Andy Ryan;M. Burnell;Aarti Sharma;S. Lewis;S. Davies-S.-Davi
通讯作者:
U. Menon;A. Gentry-Maharaj;Rachel Hallett;Andy Ryan;M. Burnell;Aarti Sharma;S. Lewis;S. Davies-S.-Davi
DOI:
10.1067/s0002-9378(03)00579-9
发表时间:
2003-10-01
影响因子:
9.8
作者:
Barnholtz-Sloan, JS;Schwartz, AG;Munkarah, AR
通讯作者:
Munkarah, AR